Prophylactic effect of interferon-alpha for exacerbation of hepatitis B after high-dose chemotherapy.
Matano
S
S
Department of Hematology, Tonami General Hospital, Tonami, Japan. matano@p1.coralnet.or.jp
Kobayashi
K
K
Ohta
H
H
Minouchi
K
K
Sanada
T
T
Sugimoto
T
T
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004279:DNA, Viral / Q000097:blood; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008111:Liver Function Tests; D016393:Lymphoma, B-Cell / Q000150:complications / Q000188:drug therapy* / Q000532:radiotherapy / Q000628:therapy; D008297:Male; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D016879:Salvage Therapy; D014182:Transplantation, Autologous; D014750:Vincristine / Q000008:administration & dosage; D014766:Viremia / Q000209:etiology; D014775:Virus Activation
D004279:DNA, Viral; D016898:Interferon-alpha; D009607:Nitrosourea Compounds; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D016190:Carboplatin; C020766:ranimustine; D011241:Prednisone